Search results
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 2 hours agoExperts say this class of drug is exciting as it might be more effective than conventional...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 31 minutes agoLater this month, the Food and Drug Administration will consider approving Moderna's RSV...
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 3 hours agoOn 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib),...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 9 hours agoAgency eyes have zeroed in on oncology, with the FDA Oncology Center of Excellence (OCE) introducing...
FDA misses own deadline to propose ban on cancer-linked formaldehyde from hair relaxers
NBC NEWS· 21 hours agoThe proposal had come after wide-ranging studies...some of the ingredients in hair-smoothing and...
Wisconsin high school football coach unable to get chemo due to shortage dies at 60
NBC News via Yahoo News· 2 days agoLast summer, NBC News reported that 14 drugs used in cancer treatment were hard to come by. In April...
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters via Yahoo News· 3 days agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 3 days agoFood and Drug Administration (FDA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of...
FDA Issues Much-Anticipated Final Rule on Laboratory Developed Tests | JD Supra
JD Supra· 10 hours agoThe FDA will phase out its policy of LDT enforcement discretion over the next four years in five stages, transitioning to active oversight of LDTs. The U.S. Food and
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
WKBN 27 Youngstown· 6 hours ago(NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that ...